ATE366128T1 - Pharmazeutische zusammensetzung - Google Patents

Pharmazeutische zusammensetzung

Info

Publication number: ATE366128T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 2000-09-11

Application number

AT01982270T

Other languages

English (en)

Inventor

Simon Bateman

Alberto Gimona

Jurij Holinej

Jasper Huels

Sumedha Jayawardene

Argeris Karabelas

Maha Khaled

Anees Karnachi

Lochlainn Eimear Nic

Richard Macerata

Victor Sloan

Original Assignee

Novartis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-11

Filing date

2001-09-10

Publication date

2007-07-15

2001-09-10 Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh

2007-07-15 Application granted granted Critical

2007-07-15 Publication of ATE366128T1 publication Critical patent/ATE366128T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Rheumatology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT01982270T 2000-09-11 2001-09-10 Pharmazeutische zusammensetzung ATE366128T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US23165500P	2000-09-11	2000-09-11
US23226100P	2000-09-14	2000-09-14

Publications (1)

Publication Number	Publication Date
ATE366128T1 true ATE366128T1 (de)	2007-07-15

Family

ID=26925315

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01982270T ATE366128T1 (de)	2000-09-11	2001-09-10	Pharmazeutische zusammensetzung

Country Status (28)

Country	Link
US (2)	US20020061932A1 (de)
EP (1)	EP1331972B1 (de)
JP (2)	JP2004527458A (de)
KR (1)	KR20030036730A (de)
CN (1)	CN100490797C (de)
AR (1)	AR030630A1 (de)
AT (1)	ATE366128T1 (de)
AU (2)	AU1390002A (de)
BR (1)	BR0113809A (de)
CA (1)	CA2416771C (de)
CY (1)	CY1107729T1 (de)
CZ (1)	CZ2003673A3 (de)
DE (1)	DE60129238T2 (de)
DK (1)	DK1331972T3 (de)
ES (1)	ES2290181T3 (de)
HU (1)	HUP0301128A3 (de)
IL (2)	IL154238A0 (de)
MX (1)	MXPA03002105A (de)
MY (1)	MY126117A (de)
NO (1)	NO20031095D0 (de)
NZ (1)	NZ524785A (de)
PE (1)	PE20020351A1 (de)
PL (1)	PL359721A1 (de)
PT (1)	PT1331972E (de)
RU (1)	RU2316324C2 (de)
SI (1)	SI1331972T1 (de)
SK (1)	SK2902003A3 (de)
WO (1)	WO2002020090A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR036312A1 (es) *	2001-08-31	2004-08-25	Novartis Ag	Composicion farmaceutica
GB0201520D0 (en) *	2002-01-23	2002-03-13	Novartis Ag	Pharmaceutical uses
EP1492520A1 (de) *	2002-03-07	2005-01-05	Novartis AG	Pharmazeutische zusammensetzungen
JP2006501161A (ja)	2002-06-11	2006-01-12	ニトロメッドインク．	ニトロソ化および／またはニトロシル化シクロオキシゲナーゼ−２選択的阻害剤、組成物ならびに使用方法
PE20040844A1 (es)	2002-11-26	2004-12-30	Novartis Ag	Acidos fenilaceticos y derivados como inhibidores de la cox-2
TWI327913B (en) *	2003-03-12	2010-08-01	Novartis Ag	Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
US20050131028A1 (en) *	2003-09-11	2005-06-16	Pharmacia Corporation	Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
FR2898492B1 (fr) *	2006-03-15	2008-06-06	Pierre Fabre Medicament Sa	Comprimes orodispersibles de domperidone
WO2008008120A1 (en) *	2006-07-14	2008-01-17	Fmc Corporation	Solid form
US20080237823A1 (en) *	2007-01-11	2008-10-02	Analog Devices, Inc.	Aluminum Based Bonding of Semiconductor Wafers
JP2012500630A (ja) *	2008-08-22	2012-01-12	ノバルティスアーゲー	肝毒性に関連するｈｌａ対立遺伝子を有していない患者におけるｃｏｘ−２依存性障害を治療するためのｃｏｘ−２阻害剤の使用
US8227451B2 (en)	2008-11-12	2012-07-24	Auspex Pharmaceuticals	Phenylacetic acid inhibitors of cyclooxygenase
CN103773596B (zh) *	2013-12-31	2016-05-18	上海复力生物医药科技有限公司	磷虾油的制备方法
US11096924B2 (en)	2016-09-07	2021-08-24	Trustees Of Tufts College	Combination therapies using immuno-dash inhibitors and PGE2 antagonists
WO2019067634A1 (en)	2017-09-26	2019-04-04	Tesaro, Inc.	Niraparib formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH08511009A (ja) *	1993-06-08	1996-11-19	チバ−ガイギーアクチェンゲゼルシャフト	ジクロフェナックを含有する経口固体剤形の製造方法
SK284330B6 (sk) *	1996-05-17	2005-01-03	Merck & Co., Inc.	Použitie 3-fenyl-4-(4-metylsulfonyl)fenyl)-2-(5H)-furanónu
CO4960662A1 (es) *	1997-08-28	2000-09-25	Novartis Ag	Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
SA99191255B1 (ar) *	1998-11-30	2006-11-25	جي دي سيرل اند كو	مركبات سيليكوكسيب celecoxib
AR036312A1 (es) *	2001-08-31	2004-08-25	Novartis Ag	Composicion farmaceutica

2001
- 2001-09-07 AR ARP010104260A patent/AR030630A1/es unknown
- 2001-09-07 PE PE2001000900A patent/PE20020351A1/es not_active Application Discontinuation
- 2001-09-10 SK SK290-2003A patent/SK2902003A3/sk unknown
- 2001-09-10 CZ CZ2003673A patent/CZ2003673A3/cs unknown
- 2001-09-10 DE DE60129238T patent/DE60129238T2/de not_active Expired - Lifetime
- 2001-09-10 ES ES01982270T patent/ES2290181T3/es not_active Expired - Lifetime
- 2001-09-10 AU AU1390002A patent/AU1390002A/xx active Pending
- 2001-09-10 WO PCT/EP2001/010448 patent/WO2002020090A2/en active IP Right Grant
- 2001-09-10 SI SI200130773T patent/SI1331972T1/sl unknown
- 2001-09-10 KR KR10-2003-7002711A patent/KR20030036730A/ko active Search and Examination
- 2001-09-10 AT AT01982270T patent/ATE366128T1/de active
- 2001-09-10 MX MXPA03002105A patent/MXPA03002105A/es active IP Right Grant
- 2001-09-10 AU AU2002213900A patent/AU2002213900C1/en not_active Ceased
- 2001-09-10 HU HU0301128A patent/HUP0301128A3/hu unknown
- 2001-09-10 PT PT01982270T patent/PT1331972E/pt unknown
- 2001-09-10 EP EP01982270A patent/EP1331972B1/de not_active Expired - Lifetime
- 2001-09-10 IL IL15423801A patent/IL154238A0/xx active IP Right Grant
- 2001-09-10 CA CA2416771A patent/CA2416771C/en not_active Expired - Fee Related
- 2001-09-10 MY MYPI20014237A patent/MY126117A/en unknown
- 2001-09-10 JP JP2002524572A patent/JP2004527458A/ja not_active Withdrawn
- 2001-09-10 CN CNB018154549A patent/CN100490797C/zh not_active Expired - Fee Related
- 2001-09-10 NZ NZ524785A patent/NZ524785A/en unknown
- 2001-09-10 RU RU2003109606/15A patent/RU2316324C2/ru not_active IP Right Cessation
- 2001-09-10 BR BR0113809-0A patent/BR0113809A/pt not_active Application Discontinuation
- 2001-09-10 PL PL35972101A patent/PL359721A1/xx not_active Application Discontinuation
- 2001-09-10 DK DK01982270T patent/DK1331972T3/da active
- 2001-09-11 US US09/950,538 patent/US20020061932A1/en not_active Abandoned
2003
- 2003-01-30 IL IL154238A patent/IL154238A/en not_active IP Right Cessation
- 2003-03-10 NO NO20031095A patent/NO20031095D0/no not_active Application Discontinuation
2004
- 2004-03-24 US US10/807,734 patent/US20040186179A1/en not_active Abandoned
2007
- 2007-09-07 CY CY20071101157T patent/CY1107729T1/el unknown
2011
- 2011-03-09 JP JP2011051754A patent/JP2011144194A/ja active Pending

Also Published As

Publication number	Publication date
SI1331972T1 (sl)	2007-12-31
WO2002020090A3 (en)	2003-05-30
AU2002213900B2 (en)	2006-02-16
US20040186179A1 (en)	2004-09-23
HUP0301128A2 (hu)	2003-10-28
US20020061932A1 (en)	2002-05-23
IL154238A0 (en)	2003-09-17
ES2290181T3 (es)	2008-02-16
HUP0301128A3 (en)	2005-04-28
NO20031095L (no)	2003-03-10
CZ2003673A3 (cs)	2003-06-18
DE60129238T2 (de)	2008-03-06
SK2902003A3 (en)	2003-10-07
EP1331972B1 (de)	2007-07-04
JP2011144194A (ja)	2011-07-28
NZ524785A (en)	2005-10-28
PT1331972E (pt)	2007-10-16
DE60129238D1 (de)	2007-08-16
CY1107729T1 (el)	2013-04-18
AU1390002A (en)	2002-03-22
CN100490797C (zh)	2009-05-27
AU2002213900C1 (en)	2006-07-27
RU2316324C2 (ru)	2008-02-10
PL359721A1 (en)	2004-09-06
AR030630A1 (es)	2003-08-27
PE20020351A1 (es)	2002-06-14
WO2002020090A9 (en)	2003-10-30
DK1331972T3 (da)	2007-11-05
MXPA03002105A (es)	2003-06-19
CA2416771A1 (en)	2002-03-14
CN1455691A (zh)	2003-11-12
KR20030036730A (ko)	2003-05-09
EP1331972A2 (de)	2003-08-06
NO20031095D0 (no)	2003-03-10
CA2416771C (en)	2010-11-02
WO2002020090A2 (en)	2002-03-14
IL154238A (en)	2008-11-26
MY126117A (en)	2006-09-29
BR0113809A (pt)	2003-07-29
JP2004527458A (ja)	2004-09-09

Publication	Publication Date	Title
ATE468324T1 (de)	2010-06-15	Pharmazeutische zusammensetzung
DE60106623D1 (de)	2004-11-25	Neue pharmazeutische zusammensetzung
AT7729U3 (de)	2006-01-15	Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657A (fi)	2010-06-10	Farmaseuttisia koostumuksia
ATE404180T1 (de)	2008-08-15	Geschmacksmaskierte pharmazeutische partikel
NO20025450L (no)	2002-11-14	Ny farmasöytisk sammensetning
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
NO20015175D0 (no)	2001-10-23	Farmasöytisk sammensetning
ATE331529T1 (de)	2006-07-15	Antigen enthaltende pharmazeutische zusammensetzung
NO20030627L (no)	2003-04-08	Hydrogel-drevet medikament doseringsform
FI20011478A (fi)	2003-01-06	Farmaseuttinen koostumus
ATE307571T1 (de)	2005-11-15	Pharmazeutische formulierung enthaltend bicalutamid
ATE334656T1 (de)	2006-08-15	Flüssige pharmazeutische zusammensetzung
EE05020B1 (et)	2008-06-16	Glburiidi ravimkoostis
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
DE60129238D1 (de)	2007-08-16	Pharmazeutische zusammensetzung
DE60217390D1 (de)	2007-02-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
FI20022128A (fi)	2003-06-06	Farmaseuttinen koostumus
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
EP1124557A4 (de)	2002-08-07	Pharmazeutische zusammensetzung
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
ATE350029T1 (de)	2007-01-15	Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung

Legal Events

Date	Code	Title	Description
2007-11-15	UEP	Publication of translation of european patent specification	Ref document number: 1331972 Country of ref document: EP

Date

Code

Title

Description

2007-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1331972

Country of ref document: EP